Qualio nabs $50M for electronic management software
Qualio has closed $50 million in funding to expand accessibility to its electronic quality management software and services for life sciences customers globally, as well as invest in product and engineering team growth. Read More
IsoPlexis acquires sequencing methodology IP
IsoPlexis has acquired an intellectual property (IP) portfolio of 86 patents related to DNA and RNA sequencing, which it is integrating into its single-cell proteomics platforms to enable a series of next-generation assays that incorporate multiple omic modalities. Read More
Therapeutic Solutions files patent for stem cell-based cancer vaccine
Therapeutic Solutions International has filed a patent for data that show a positive combined effect between its tumor blood vessel killing vaccine and particular immunological adjuvants. Read More
Pfizer to study pneumococcal, COVID-19 vaccine combo in older adults
Pfizer has launched a study that is investigating the coadministration of the company's pneumococcal vaccine (20vPnC) and its Pfizer-BioNTech COVID-19 vaccine in adults 65 and older. Read More
Moderna inks South Korean mRNA vaccine collaborations
Moderna has inked two memoranda of understanding agreements with South Korea for messenger RNA (mRNA) vaccine research and manufacturing in that country. Read More
Boehringer Ingelheim to advance Dicerna RNAi candidate
Boehringer Ingelheim has accepted Dicerna Pharmaceuticals GalXC RNA interference (RNAi) candidate for its development for the treatment of chronic liver diseases. Read More
EMA gives positive nod to GSK, Vir COVID-19 mAb
GlaxoSmithKline (GSK) and Vir Biotechnology today announced that the European Medicines Agency's (EMA) Committee for Human Medicinal Products has issued a positive scientific opinion following the referral of sotrovimab, a monoclonal antibody (mAb) to the EMA committee. Read More
Therapeutic Solutions advances its COVID-19 stem cell-based therapy
Therapeutic Solutions International announced new data and a patent filing demonstrating that lithium carbonate augments the scar-inhibiting activity of its JadiCell universal donor stem cell therapy. Read More
Japan approves Moderna COVID-19 vaccine
Japan's Ministry of Health, Labour, and Welfare recently approved Moderna's COVID-19 vaccine, and distribution in the country by Takeda will begin immediately. Read More
Japan approves AstraZeneca COVID-19 vaccine
Japan recently granted special approval for emergency use of AstraZeneca's COVID-19 vaccine, Vaxzevria, in patients ages 18 years and older. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
